Donor-derived memory T cells genetically engineered to express an NKG2D-based chimeric antigen receptor targeting stress-induced NKG2D ligands (MICA/MICB/ULBPs) on tumor cells, intended to trigger T-cell cytotoxicity and overcome immune evasion; administered intravenously with optional intratumoral injection after lymphodepleting conditioning.
Donor-derived memory T cells are genetically engineered to express an NKG2D-based chimeric antigen receptor that recognizes stress-induced NKG2D ligands (MICA/MICB/ULBPs) on tumor cells, leading to CAR-mediated T-cell activation, cytokine release, and targeted cytotoxic killing, with the memory phenotype supporting persistence and the approach aiming to overcome tumor immune evasion.
NKG2D-CAR T cells recognize MICB via the NKG2D-based CAR, leading to T-cell activation and contact-dependent killing through perforin/granzyme release and Fas/FasL-mediated apoptosis.
Donor-derived memory T cells genetically engineered to express an NKG2D-based chimeric antigen receptor targeting stress-induced NKG2D ligands (MICA/MICB/ULBPs) on tumor cells, intended to trigger T-cell cytotoxicity and overcome immune evasion; administered intravenously with optional intratumoral injection after lymphodepleting conditioning.
Donor-derived memory T cells are genetically engineered to express an NKG2D-based chimeric antigen receptor that recognizes stress-induced NKG2D ligands (MICA/MICB/ULBPs) on tumor cells, leading to CAR-mediated T-cell activation, cytokine release, and targeted cytotoxic killing, with the memory phenotype supporting persistence and the approach aiming to overcome tumor immune evasion.
NKG2D-CAR T cells recognize ULBP1 on target cells, triggering T-cell activation and immune synapse formation, leading to perforin/granzyme-mediated apoptosis (and related T-cell effector mechanisms).
Donor-derived memory T cells genetically engineered to express an NKG2D-based chimeric antigen receptor targeting stress-induced NKG2D ligands (MICA/MICB/ULBPs) on tumor cells, intended to trigger T-cell cytotoxicity and overcome immune evasion; administered intravenously with optional intratumoral injection after lymphodepleting conditioning.
Donor-derived memory T cells are genetically engineered to express an NKG2D-based chimeric antigen receptor that recognizes stress-induced NKG2D ligands (MICA/MICB/ULBPs) on tumor cells, leading to CAR-mediated T-cell activation, cytokine release, and targeted cytotoxic killing, with the memory phenotype supporting persistence and the approach aiming to overcome tumor immune evasion.
NKG2D-CAR T cells recognize ULBP2 on target cells, triggering CAR signaling and T-cell effector functions that kill the bound cell via perforin/granzyme release and death-receptor–mediated apoptosis.
Donor-derived memory T cells genetically engineered to express an NKG2D-based chimeric antigen receptor targeting stress-induced NKG2D ligands (MICA/MICB/ULBPs) on tumor cells, intended to trigger T-cell cytotoxicity and overcome immune evasion; administered intravenously with optional intratumoral injection after lymphodepleting conditioning.
Donor-derived memory T cells are genetically engineered to express an NKG2D-based chimeric antigen receptor that recognizes stress-induced NKG2D ligands (MICA/MICB/ULBPs) on tumor cells, leading to CAR-mediated T-cell activation, cytokine release, and targeted cytotoxic killing, with the memory phenotype supporting persistence and the approach aiming to overcome tumor immune evasion.
NKG2D-CAR T cells bind ULBP3 on target cells, triggering CAR activation and T-cell cytotoxicity (perforin/granzyme-mediated apoptosis, with possible Fas–FasL), directly killing ULBP3+ cells.
Donor-derived memory T cells genetically engineered to express an NKG2D-based chimeric antigen receptor targeting stress-induced NKG2D ligands (MICA/MICB/ULBPs) on tumor cells, intended to trigger T-cell cytotoxicity and overcome immune evasion; administered intravenously with optional intratumoral injection after lymphodepleting conditioning.
Donor-derived memory T cells are genetically engineered to express an NKG2D-based chimeric antigen receptor that recognizes stress-induced NKG2D ligands (MICA/MICB/ULBPs) on tumor cells, leading to CAR-mediated T-cell activation, cytokine release, and targeted cytotoxic killing, with the memory phenotype supporting persistence and the approach aiming to overcome tumor immune evasion.
NKG2D-CAR T cells recognize ULBP4 on target cells, triggering CAR signaling and T-cell cytotoxicity via immune synapse formation with perforin/granzyme release (and Fas/FasL), inducing apoptosis of the target cell.